论文部分内容阅读
目的观察康复新液联合泮托拉唑治疗消化性溃疡的疗效并评价其安全性。方法选取医院收治的消化性溃疡患者60例作为研究对象,随机分为独立组和联合组,每组30例。独立组采用泮托拉唑治疗,联合组在独立组治疗基础上加用康复新液治疗,观察2组用药后治疗总有效率及不良反应发生率。结果经治疗,联合组治疗总有效率为96.67%,高于独立组的80.00%(P<0.05);联合组不良反应发生率为10.00%,独立组不良反应发生率为6.67%,2组比较差异无统计学意义(P>0.05)。结论使用康复新液联合泮托拉唑治疗消化性溃疡疗效显著,用药安全性高,具有较高的临床应用价值。
Objective To observe the curative effect of Kangfuxin Solution combined with pantoprazole on peptic ulcer and evaluate its safety. Methods Sixty patients with peptic ulcer admitted to hospital were selected as the research object and randomly divided into independent group and combined group, 30 cases in each group. The independent group was treated with pantoprazole. The combination group was treated with Kangfuxinye on the basis of the independent group. The total effective rate and the incidence of adverse reactions after the two groups were observed. Results After treatment, the total effective rate of the combination group was 96.67%, higher than that of the independent group (80.00%, P <0.05). The incidence of adverse reactions in the combined group was 10.00% and that of the independent group was 6.67% The difference was not statistically significant (P> 0.05). Conclusions The use of Kangfuxin Solution combined with pantoprazole in the treatment of peptic ulcer has significant curative effect, high drug safety and high clinical value.